Sort
82,697 grants matching “vaccine development”
CMV Subunit Vaccine in Young Women at Risk
$973,147Robert Floyd Pass · University Of Alabama At Birmingham · U01 · FY2006 · AI
Protection Against Inhalation Anthrax with Inactivated Spores
$973,092Donald G. Guiney · University Of California, San Diego · U01 · FY2008 · AI
Collaborative Modeling for Assessment and Optimization in Public Health
$973,020Marc Lipsitch · Harvard School Of Public Health · U54 · FY2015 · GM
In vivo dose finding for an antibody based nonhormonal contraceptive intravaginal ring
$972,804Richard A Cone · Mucommune, Llc · R44 · FY2020 · HD
CMV Subunit Vaccine in Young Women at Risk
$972,591University Of Alabama At Birmingham · U01 · FY2005 · AI
4-(Aminomethyl) benzamides as novel anti-Ebola agents
$972,475Lijun Rong · Chicago Biosolutions, Inc. · R42 · FY2019 · AI
Novel G protein-based RSV vaccine
$972,321Shengqiang Li · Sciogen, Llc · R44 · FY2025 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$972,285Neel Rajnikant Gandhi · Emory University · P30 · FY2023 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$972,283Neel Rajnikant Gandhi · Emory University · P30 · FY2025 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$972,283Neel Rajnikant Gandhi · Emory University · P30 · FY2024 · AI
Regulation of self-tolerance and adaptive immunity by cell death and other cues
$972,222Christian Mayer · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
DESIGN OF NOVEL IMMUNOGENS AND ADJUVANTS FOR HIV VACCINE
$972,206Duke University · P01 · FY2000 · AI
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
$972,133Jae U Jung · Cleveland Clinic Lerner Com-Cwru · U01 · FY2025 · CA
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts
$972,111Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2020 · AI
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$972,063Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2022 · DE
Accelerated molecular probe pipeline
$971,923Gerard A Cangelosi · Seattle Biomedical Research Institute · U01 · FY2010 · AI
Core-002
$971,739Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2025 · AI
Structural Biology Of Virus Assembly
$971,514Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Microneedle Delivery of Zanamivir for Treatment of Influenza
$971,504Elke Lipka · Tsrl, Inc. · R44 · FY2020 · AI
Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination
$971,500Pamela J Bjorkman · Rockefeller University · P01 · FY2023 · AI
Vaccines and Therapeutics for Anthrax
$971,268Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Oral, replicating Ad4-HIV vaccine development & evaluation in NHP challenge model
$971,235Marc Joseph Gurwith · Paxvax, Inc. · R44 · FY2014 · AI
Development of Influenza Virus-Like Particle (VLP) Vaccines
$971,080Jose M Galarza · Technovax, Inc. · R44 · FY2010 · AI
HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP
$971,055Jeffery Alexander · Paxvax, Inc. · R44 · FY2016 · AI
DEVELOPMENT OF A PRIMATE GENOMIC RESOURCE
$970,964Michael G Katze · University Of Washington · R24 · FY2008 · RR